Back to results
US 11,230,551 B2Granted
Deuterated analogs of MK2 inhibitors and uses thereof
AssigneeCelgene CAR LLC
InventorsJohn Malona, Sekhar S. Surapaneni
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
Claims13
A compound of Formulae IV, IV′, or IV″:
- or a pharmaceutically acceptable salt thereof, whererin:
- each of R7, R7′, R8, R8′, R8″, and R9 is independently selected from hydrogen or deuterium;
- provided that at least one of R7, R7′, R8, R8′, R8″, and R9 is deuterium.
Dependencies are inferred from the claim text.